Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial - The ...
Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial - The Lancet Diabetes
Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements - Scott M. Pearson, Jennifer M. Trujillo, 2018
Starting, Titrating and Adding to Therapy
Risultati del confronto tra insulina glargine e insulina degludec • NCF
View of Insulin U100, 200, 300 or 500? | British Journal of Diabetes
fig5.gif
Tresiba vs. Lantus: How these drugs compare
Update on Basal Insulin Therapy for Type 2 Diabetes Mellitus
Tresiba vs. Lantus: Differences and Similarities | InsulinStore
Levemir vs Lantus, Uses, Dosage, Side Effects, and Price
Is Lantus better at controlling blood sugar than Tresiba? - Quora
Tresiba vs Lantus for Diabetes: What's the difference?
Tresiba vs. Lantus: Differences, similarities, and which is better for you
Lantus vs. Toujeo: What's the difference? - YouTube
Insulin Therapy: The Old, the New and the Novel-An Overview. | Semantic Scholar